Lara Pharm Ltd develops pharmaceutical-grade cannabinoids and related technology. By developing a way to mass-produce standardized cannabis-based prescription drugs,Lara Pharmseeks to eliminate the need for medical marijuana. The company has developed an inhaler that delivers a controlled dose of cannabinoids.
Lara Pharm was acquired by Israeli Therapix Biosciences Ltd. (TASE: TRPH, formerly NasVax), back in August 2014.